MedTrace Logo

Pharmacokinetics Study of Azilsartan Tablets in Chinese Healthy Volunteers

NCT02786082 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2018-09-05

No results posted yet for this study

Summary

The main objective is to study the pharmacokinetics of Azilsartan Tablets in human and providing evidence for clinical study and clinical application of this product.

Conditions

Interventions

DRUG

20mg Azilsartan Tablets

Strength: 20mg, oral administration 1 tablet/ day

DRUG

40mg Azilsartan Tablets

Strength: 40mg, oral administration 1 tablet/ day

Sponsors & Collaborators

  • Lee's Pharmaceutical Limited

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-11-01
Primary Completion
2017-08-31
Completion
2017-11-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02786082 on ClinicalTrials.gov